| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.77B | 5.23B | 4.82B | 3.68B | 3.93B |
| Gross Profit | 1.78B | 1.48B | 1.45B | 1.18B | 1.23B |
| EBITDA | 1.01B | 760.00M | 773.98M | 637.98M | 667.60M |
| Net Income | 458.44M | 256.74M | 299.22M | 222.13M | 204.69M |
Balance Sheet | |||||
| Total Assets | 6.92B | 5.94B | 5.71B | 5.38B | 5.35B |
| Cash, Cash Equivalents and Short-Term Investments | 1.81B | 949.82M | 619.65M | 664.39M | 556.34M |
| Total Debt | 405.73M | 412.33M | 304.63M | 300.10M | 416.91M |
| Total Liabilities | 1.03B | 728.26M | 661.68M | 536.77M | 629.47M |
| Stockholders Equity | 5.62B | 5.21B | 5.05B | 4.85B | 4.72B |
Cash Flow | |||||
| Free Cash Flow | 967.17M | 692.87M | 301.69M | 568.34M | 939.27M |
| Operating Cash Flow | 1.10B | 769.08M | 403.59M | 605.58M | 973.56M |
| Investing Cash Flow | -278.25M | 62.01M | -66.48M | -220.44M | -17.44M |
| Financing Cash Flow | -258.88M | -375.06M | -344.38M | -466.27M | -808.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$2.29B | 3.61 | 5.10% | 4.05% | 10.23% | 66.75% | |
73 Outperform | HK$13.37B | 5.90 | 9.57% | 4.43% | 10.89% | 2.02% | |
70 Outperform | HK$1.60B | 4.06 | 10.00% | 9.67% | -9.00% | -21.55% | |
64 Neutral | HK$107.63B | 15.23 | 23.29% | 4.21% | -9.49% | 32.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | HK$748.68M | -20.98 | -1.15% | ― | -37.78% | 57.76% | |
48 Neutral | HK$348.15M | -1.28 | -7.92% | ― | -17.82% | 16.27% |